The prognostic role of gamma-glutamyltransferase activity in non-diabetic ST-elevation myocardial infarction

Internal and Emergency Medicine

Volumn 6, Issue 3, 2011, Pages 213-219

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Tarquini, Roberto ^a   Chiostri, Marco ^a   Picariello, Claudio ^a   Gensini, Gian Franco ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Gamma glutamyltransferase; Percutaneous coronary intervention; Prognosis; ST elevation myocardial infarction

Indexed keywords

EID: 85027930291     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-010-0464-8     Document Type: Article

References (40)

1. Rahman I, MacNee W (2000) Oxidative stress and regulation of glutathione in lung inflammation. EurRespir J 16: 534-554.
2. Hochwald SN, Harrison LE, Rose DM, Anderson M, Burt ME (1996) Gamma-glutamyltranspeptidase mediation of tumor glutathione utilization in vivo. J Natl Cancer Inst 88: 193-197.
3. Karp DR, Shimooku K, Lipsky PE (2001) Expression of gamma-glutamyltranspeptidase protects ramos B cells from oxidation-induced cell death. J Biol Chem 276: 3798-3804.
4. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C et al (2004) Atherosclerotic plaques contain gamma-glutamyltranspeptidase activity. Circulation 109: 1140.
5. Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A (1997) Gammaglutamyltranspeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free RadicBiol Med 22: 853-860.
6. Wannamethee G, Ebrahim S, Shaper AG (1995) Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 142: 699-708.
7. Pompella A, Emdin M, Passino C, Paolicchi A (2004) The significance of serum γ-glutamyltransferase in cardiovascular diseases. Clin Chem Lab Med 42: 1085-1091.
8. Lee DH, Silventoinen K, Hu G, Jacobs DR Jr, Jousilahti P et al (2006) Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28, 838 middleaged men and women. Eur Heart J 27: 2170-2176.
9. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J et al (2003) Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 49: 1358-1366.
10. Meisinger C, Doring A, Schneider A, Lowel H, KORA Study Group (2006) Serum gamma-glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 189: 297-302.
11. Ruttmann E, Brant LJ, Concin H, Diem G, Rapp K, Ulmer H (2005) Gammaglutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiologic investigation in a cohort of 163 944 Austrian adults. Circulation 112: 2130-2137.
12. Emdin M, Passino C, Michelassi C, Titta F, L'abbate A, Donato L et al (2001) Prognostic value of serum gamma-glutamyltransferase activity after myocardial infarction. Eur Heart J 22: 1802-1807.
13. Wannamethee SG, Lennon L, Shaper AG (2008) The value of gamma-glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 201(1): 168-175.
14. Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U, Schilling D, Winkelmann BR, Boehm BO, März W (2010) Serum gamma-glutamyltransferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 208(2): 564-571.
15. Demircan S, Yazici M, Durna K, Kilicaslan F, Demir S, Pinar M, Gulel O (2009) The importance of gamma-glutamyltransferase activity in patients with coronary artery disease. ClinCardiol 32(4): 220-225.
16. Ulus T, Yildirir A, Sade LE, Temiz A, Polat E, Bozbaş H, Aydinalp A, Eroǧlu S, Ozin B, Müderrisoǧlu H (2008) Serum gamma-glutamyltransferase activity: new high risk criteria in acute coronary patients. Coron Artery Dis 19(7): 489-495.
17. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS (2007) Gamma-glutamyltransferase and metabolic syndrome, cardiovascular disease and mortality risk the Framingham Heart study. ArteriosclerThrombVasc Biol 27(1): 127-133.
18. van de Werf F, Bax J, Betriu A et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 29(23): 2909-2945.
19. Valente S, Lazzeri C, Chiostri M et al (2009) NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol 132(1): 84-89.
20. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9): 604-612.
21. Balkau B, Charles M (1999) for the European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO Consultation. Diabet Med 16: 442-443.
22. Lazzeri C, Valente S, Chiostri M, Picariello C, MD GensiniGF (2010) Acute glucose dysmetabolism in the early phase of ST-elevation myocardial infarction: the age response. Diab Vasc Dis Res 7(2): 131-137.
23. Lazzeri C, Sori A, Chiostri M et al (2009) Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 26(10): 856-862.
24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F (2005) Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
25. Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2(5-6): 231-237.
26. Ceriello A, Zarich SW, Testa R (2009) Lowering glucose to prevent adverse cardiovascular outcomes in a critical care setting. J Am Coll Cardiol 53: S9-S13.
27. Lazzeri C, Tarquini R, Giunta F, Gensini GF (2009) Glucose dysmetabolism and prognosis in critical illness. Intern Emerg Med 4(2): 147-156.
28. Deedwania P, Kosiborod M, Barrett E et al, American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity and Metabolism (2008) Hyperglycemia and acute coronary syndrome: a scientific statement from the American heart association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation 117(12): 1610-1619.
29. Karlson BW, Wiklund O, Hallgren P, Sjölin M, Lindqvist J, Herlitz J (2000) Ten-year mortality amongst patients with a very small or unconfirmed acute myocardial infarction in relation to clinical history, metabolic screening and signs of myocardial ischaemia. J Intern Med 247(4): 449-456.
30. Lazzeri C, Valente S, Chiostri M, Picariello C, Gensini GF (2010) In hospital peak glycemia and prognosis in STEMI patients without previously known diabetes. Eur J Cardiovasc Prev Rehabil 17(4): 419-423.
31. Shin JY, Chang SJ, Shin YG, Seo KS, Chung CH (2009) Elevated serum gamma-glutamyltransferase levels are independently associated with insulin resistance in non-diabetic subjects. Diabetes Res Clin Pract 84(2): 152-157 (epub 4 March 2009).
32. Lazzeri C, Valente S, Chiostri M, Sori A, Bernardo P, Gensini GF (2010) Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers a single center experience. Int J Cardiol 138(2): 206-209.
33. Celik T, Iyisoy A (2009) Uric acid levels for the prediction of prognosis in patients with acute ST elevation myocardial infarction: a new potential biomarker. Int J Cardiol (Epub ahead of print).
34. Car S, Trkulja V (2009) Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study. Croat Med J 50(6): 559-566.
35. Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359: 1811-1821.
36. Emdin M, Pompella A, Paolicchi A (2005) Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 112: 2078-2080.
37. Ulus T, Yildirir A, Demirtas S, Demir O, Sade LE et al (2007) Serum gamma-glutamyltransferase activity: anew marker for stent restenosis? Atherosclerosis 195: 348-353.
38. Paolicchi A, Minotti G, Tonarelli P, Tongiani R, De Cesare D et al (1999) Gamma-glutamyltranspeptidase-dependent iron reduction and LDL oxidation-a potential mechanism in atherosclerosis. J Investig Med 47: 151-160.
39. Ishizaka N, Ishizaka Y, Toda E, Yamakado M, Koike K, Nagai R (2010) Association between gamma-glutamyltransferase levels and insulin resistance according to alcohol consumption and number of cigarettes smoked. J Atheroscler Thromb 17(5): 476-485.
40. Turgut O, Tandogan I, Gurlek A (2009) Association of gamma-glutamyltransferase with cardiovascular risk: a prognostic outlook. Arch Med Res 40(4): 318-320.